Skip to content

The risk stratification, treatment strategy, and clinical prognosis of emergency patients with aortic intermural hematoma: a prospective cohort study

The risk stratification, treatment strategy, and clinical prognosis of emergency patients with aortic intermural hematoma: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090928
Enrollment
Unknown
Registered
2024-10-16
Start date
2024-10-17
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic intermural hematoma

Interventions

Case series:None

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old, male or female; 2. All emergency room visitors with a primary diagnosis of "intermural hematoma of the aorta"; 3. Sign the informed consent form; 4. Patients who are not enrolled in other interventional clinical studies.

Exclusion criteria

Exclusion criteria: 1. Incapacitated or capacity-restricted; 2. Already enrolled in other interventional clinical studies; 3. Refusing to sign the study informed consent form; 4. Other conditions that the investigator considers inappropriate for participation.

Design outcomes

Primary

MeasureTime frame
1-year incidence of major adverse cardiovascular events;

Secondary

MeasureTime frame
All-cause death;Aortic related death;

Countries

China

Contacts

Public ContactLv Siqi

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

lvsiqi138@163.com+86 188 0016 1566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026